Tokai Pharmaceuticals Inc. (Nasdaq: TKAI) entered a share purchase agreement under which shareholders of Otic Pharma Ltd. would become majority owners of Tokai. The stock price gained 20 cents to close at $1.21.
Tokai enters share purchase agreement
December 22, 2016 at 18:22 PM EST
